Patients with postmenopausal ER-positive advanced recurrent breast cancer
Conditions
Interventions
None listed
Sponsors
Japan Breast Cancer Research Group(JBCRG)
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria:
Exclusion criteria
Exclusion criteria: 1)Patients not agree with this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effects of clinical background and prior therapies on the treatment time with Fulvestrant (TTF) | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary analysis 1.Effects of clinical background and prior therapies on overall survival (OS) after start of Fulvestrant 2.Descriptive statistics of treatment 3.Summary of therapies administered to subjects with long survival | — |
Countries
Japan
Contacts
Public ContactKatsumasa Kuroi
Japan Breast Cancer Research Group (JBCRG) Adminstrative office
Outcome results
None listed